The US government announced 29 July it has secured 66 million doses of Moderna, Inc.’s bivalent Omicron-BA.4/BA.5 directed COVID-19 vaccine for $1.74bn, bringing the total US supply of updated booster shots to 171 million – about enough to cover half of the US population in the planned fall booster campaign.
The Biden administration pulled money from other COVID-19 efforts like at-home testing to purchase the new vaccines. It has options...







